Results
258
Most Popular Stocks on the market
258 companies
Samsung BiologicsLtd
Market Cap: ₩74.8t
Engages in the contract development and manufacturing organization (CDMO) business for biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,051,000.00
7D
-4.5%
1Y
27.2%
Celltrion
Market Cap: ₩40.0t
Develops and produces drugs based on proteins for the treatment of oncology in South Korea.
A068270
₩186,100.00
7D
1.1%
1Y
8.1%
ALTEOGEN
Market Cap: ₩20.9t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩392,000.00
7D
6.4%
1Y
91.7%
Yuhan
Market Cap: ₩9.3t
Manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally.
A000100
₩124,800.00
7D
5.0%
1Y
68.6%
SK Biopharmaceuticals
Market Cap: ₩8.3t
A pharmaceutical company, engages in the research and development of drugs for the treatment of central nervous system disorders.
A326030
₩106,600.00
7D
-0.3%
1Y
13.5%
Sam Chun Dang Pharm
Market Cap: ₩4.5t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩191,400.00
7D
-1.6%
1Y
146.0%
Kolon TissueGene
Market Cap: ₩4.2t
Develops cell therapies to target various orthopedic diseases and degenerative disorders.
A950160
₩51,700.00
7D
33.2%
1Y
309.0%
LigaChem Biosciences
Market Cap: ₩3.7t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩103,300.00
7D
-1.5%
1Y
49.7%
Hugel
Market Cap: ₩3.6t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩330,000.00
7D
9.1%
1Y
73.0%
PharmaResearch
Market Cap: ₩3.5t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩335,500.00
7D
10.0%
1Y
267.5%
SK bioscienceLtd
Market Cap: ₩3.3t
Engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally.
A302440
₩42,750.00
7D
3.6%
1Y
-29.3%
Hanmi Pharm
Market Cap: ₩3.1t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩245,000.00
7D
-1.2%
1Y
-23.8%
Voronoi
Market Cap: ₩2.5t
Researches, develops, and discovers small molecule kinase inhibitors in South Korea.
A310210
₩136,600.00
7D
-8.2%
1Y
265.2%
Celltrion Pharm
Market Cap: ₩2.3t
A pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea.
A068760
₩53,400.00
7D
0.8%
1Y
-48.0%
Peptron
Market Cap: ₩2.1t
Engages in the development of peptide-based medicines.
A087010
₩88,000.00
7D
-3.6%
1Y
256.3%
ABL Bio
Market Cap: ₩1.8t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩37,650.00
7D
-2.6%
1Y
49.1%
Hanall Biopharma
Market Cap: ₩1.8t
A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.
A009420
₩34,800.00
7D
-1.3%
1Y
-3.3%
ST PharmLtd
Market Cap: ₩1.5t
Provides custom manufacturing services for active pharmaceutical ingredient and intermediates in South Korea and internationally.
A237690
₩75,600.00
7D
0.7%
1Y
-2.6%
GC Biopharma
Market Cap: ₩1.5t
A biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally.
A006280
₩128,500.00
7D
-0.8%
1Y
7.5%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Manufactures and sells pharmaceutical products in South Korea and internationally.
A069620
₩119,900.00
7D
-3.2%
1Y
6.2%
Caregen
Market Cap: ₩1.3t
A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.
A214370
₩26,650.00
7D
6.4%
1Y
11.3%
Oscotec
Market Cap: ₩1.2t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩31,700.00
7D
-0.5%
1Y
16.3%
Seegene
Market Cap: ₩1.1t
Manufactures and sells molecular diagnostics products worldwide.
A096530
₩24,650.00
7D
-0.6%
1Y
1.9%
Chong Kun Dang Pharmaceutical
Market Cap: ₩1.0t
Engages in the manufacturing, marketing, and sales of medicines in South Korea and internationally.
A185750
₩79,300.00
7D
-0.5%
1Y
-21.2%
HK inno.N
Market Cap: ₩1.0t
Engages in the pharmaceutical business in South Korea.
A195940
₩36,400.00
7D
0%
1Y
0.7%
NatureCellLtd
Market Cap: ₩1.0t
Engages in manufacturing and selling of canned and health functional food products, beverages, stem cell, and cosmetics in South Korea.
A007390
₩15,770.00
7D
-0.4%
1Y
125.6%
OliX Pharmaceuticals
Market Cap: ₩925.8b
A clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases.
A226950
₩49,700.00
7D
3.0%
1Y
202.5%
Medy-Tox
Market Cap: ₩870.4b
Operates as a biopharmaceutical company in South Korea.
A086900
₩130,700.00
7D
8.6%
1Y
-8.0%
Mezzion PharmaLtd
Market Cap: ₩824.0b
Develops, manufactures, and sells pharmaceutical products in South Korea.
A140410
₩27,500.00
7D
-5.5%
1Y
-33.1%
Boryung
Market Cap: ₩809.4b
Engages in the manufacture and sale of pharmaceutical products in South Korea and internationally.
A003850
₩9,640.00
7D
-1.9%
1Y
-25.2%
Daewoong
Market Cap: ₩794.5b
Engages in the manufacture and sale of pharmaceuticals in South Korea.
A003090
₩19,430.00
7D
-1.6%
1Y
-0.1%
Pharmicell
Market Cap: ₩741.6b
A biopharmaceutical company, develops and sells stem cell drugs in South Korea and internationally.
A005690
₩12,360.00
7D
21.8%
1Y
109.8%
GI Innovation
Market Cap: ₩688.1b
A bio-venture company, engages in the research and development of protein new drugs.
A358570
₩15,530.00
7D
-9.5%
1Y
27.7%
HLB TherapeuticsLtd
Market Cap: ₩669.4b
A biotech company, develops pharmaceutical products in South Korea and internationally.
A115450
₩7,990.00
7D
-19.5%
1Y
-17.2%
DongKook Pharmaceutical
Market Cap: ₩667.0b
Produces and sell pharmaceutical products in South Korea and internationally.
A086450
₩15,170.00
7D
-3.3%
1Y
-4.4%
Dong-A Socio Holdings
Market Cap: ₩642.5b
Engages in the pharmaceutical business in South Korea.
A000640
₩99,800.00
7D
4.8%
1Y
-10.0%